63 related articles for article (PubMed ID: 30399599)
1. Aminophenols increase proliferation of thyroid tumor cells by inducing the transcription factor activity of estrogen receptor α.
Wang L; Zhao L; Jia X; Jiang L; Song Y; Ye Q; Lyu Z
Biomed Pharmacother; 2019 Jan; 109():621-628. PubMed ID: 30399599
[TBL] [Abstract][Full Text] [Related]
2. Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment.
Sirianni R; Zolea F; Chimento A; Ruggiero C; Cerquetti L; Fallo F; Pilon C; Arnaldi G; Carpinelli G; Stigliano A; Pezzi V
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2238-50. PubMed ID: 23074235
[TBL] [Abstract][Full Text] [Related]
3. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide re-sensitizes ERα-negative breast cancer cells to endocrine therapy by restoring ERα expression in vitro and in vivo.
Zhang W; Wang L; Fan Q; Wu X; Wang F; Wang R; Ma Z; Yang J; Lu SH
Oncol Rep; 2011 Sep; 26(3):621-8. PubMed ID: 21687957
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
Keeton EK; Brown M
Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and Estrogen Receptor-α-Mediated Transrepression of Bile Salt Export Pump.
Chen Y; Vasilenko A; Song X; Valanejad L; Verma R; You S; Yan B; Shiffka S; Hargreaves L; Nadolny C; Deng R
Mol Endocrinol; 2015 Apr; 29(4):613-26. PubMed ID: 25675114
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.
Matthews J; Wihlén B; Thomsen J; Gustafsson JA
Mol Cell Biol; 2005 Jul; 25(13):5317-28. PubMed ID: 15964790
[TBL] [Abstract][Full Text] [Related]
8. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
9. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
10. [Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice].
Zhang WJ; Xu DF; Fan QX; Wu XA; Wang F; Wang R; Wang LX
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):645-51. PubMed ID: 23159075
[TBL] [Abstract][Full Text] [Related]
11. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.
Chang J; Sui M; Fan W
Breast Cancer Res Treat; 2012 Aug; 134(3):969-80. PubMed ID: 22374518
[TBL] [Abstract][Full Text] [Related]
13. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
[TBL] [Abstract][Full Text] [Related]
14. The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas.
Zeng Q; Chen G; Vlantis A; Tse G; van Hasselt C
J Pathol; 2008 Mar; 214(4):425-33. PubMed ID: 18085520
[TBL] [Abstract][Full Text] [Related]
15. Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.
Barcus CE; O'Leary KA; Brockman JL; Rugowski DE; Liu Y; Garcia N; Yu M; Keely PJ; Eliceiri KW; Schuler LA
Breast Cancer Res; 2017 Jan; 19(1):9. PubMed ID: 28103936
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
Han L; Liu B; Jiang L; Liu J; Han S
Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters.
Cheng AS; Jin VX; Fan M; Smith LT; Liyanarachchi S; Yan PS; Leu YW; Chan MW; Plass C; Nephew KP; Davuluri RV; Huang TH
Mol Cell; 2006 Feb; 21(3):393-404. PubMed ID: 16455494
[TBL] [Abstract][Full Text] [Related]
18. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.
Wang X; Yang Z; Zhang H; Ding L; Li X; Zhu C; Zheng Y; Ye Q
Biochim Biophys Acta; 2008 Jun; 1783(6):1220-8. PubMed ID: 18302941
[TBL] [Abstract][Full Text] [Related]
19. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
Laganière J; Deblois G; Giguère V
Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
[TBL] [Abstract][Full Text] [Related]
20. Hispolon inhibits the growth of estrogen receptor positive human breast cancer cells through modulation of estrogen receptor alpha.
Jang EH; Jang SY; Cho IH; Hong D; Jung B; Park MJ; Kim JH
Biochem Biophys Res Commun; 2015 Aug; 463(4):917-22. PubMed ID: 26056942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]